// App-Quantinova.ai

OP0033 (2021) : REGULATORY T CELL CD39 EXPRESSION AS A PREDICTOR OF EARLY REMISSION-INDUCTION WITH METHOTREXATE IN NEW-ONSET RHEUMATOID ARTHRITIS

Researchers

Presenter

  • P. Brown

Principal Investigators

  • A. Anderson

  • B. Hargreaves

  • A. Morgan

  • J. D. Isaacs

  • A. Pratt

Medical Centers

  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom

  • Musculoskeletal Department, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom

  • Leeds Institute of Cardiovascular and Metabolic Medicine, Discovery and Translational Science Department, School of Medicine, University of Leeds, Leeds, United Kingdom

  • National Institute for Health Research, Leeds Biomedical Research Centre, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved